
|Articles|March 20, 2020
snapIoT Launches Mobile Device Management Module
Advertisement
snapIoT Inc., a San Diego-based provider of snapClinical, an mClinical platform for patient-centric engagement solutions, announces its Mobile Device Management module. The Mobile Device Management module is for the management of all smart phones and devices that are used throughout digitally enabled clinical trials to help ensure security, quality, and compliance.
	For more information, click 
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
2
ACT Brief: AI, Equity, and Innovation Drive Clinical Research Forward
3
Reducing Site Burden Through Better Technology Integration in Clinical Trials
4
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
5





.png)



.png)



.png)
.png)
